Brainsway (BWAY) Operating Leases (2023 - 2026)
Brainsway posted quarterly Operating Leases of $5.6 million for Q1 2026, down 2.46% on a QoQ basis from $5.7 million in Q4 2025.
Brainsway (BWAY) has 4 years of Operating Leases data on file, last reported at $5.6 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (changed N/A YoY), and the FY2025 full-year result was $5.7 million, up 2.1% from the prior year.
- Operating Leases for Q1 2026 stood at $5.6 million, down from $5.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $5.7 million in Q4 2025 and bottomed at $239000.0 in Q4 2023.
- The 4-year median for Operating Leases is $5.6 million (2024), against an average of $4.3 million.
- The widest annual swing landed in 2024, when Operating Leases jumped 2253.14%; it then gained 2.1% in 2025.
- A 4-year view of Operating Leases shows it stood at $239000.0 in 2023, then surged by 2253.14% to $5.6 million in 2024, then grew by 2.1% to $5.7 million in 2025, then dropped by 2.46% to $5.6 million in 2026.
- The last three Operating Leases figures came in at $5.6 million (Q1 2026), $5.7 million (Q4 2025), and $5.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Brainsway | 6.80 Mn | -52.98 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 239,000.00 |